Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 593 JPY -1.12% Market Closed
Market Cap: 39.4B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Fuji Pharma Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fuji Pharma Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Current Portion of Long-Term Debt
ÂĄ7.7B
CAGR 3-Years
45%
CAGR 5-Years
18%
CAGR 10-Years
24%
Takeda Pharmaceutical Co Ltd
TSE:4502
Current Portion of Long-Term Debt
ÂĄ624.1B
CAGR 3-Years
43%
CAGR 5-Years
29%
CAGR 10-Years
14%
Daiichi Sankyo Co Ltd
TSE:4568
Current Portion of Long-Term Debt
ÂĄ400m
CAGR 3-Years
-73%
CAGR 5-Years
-60%
CAGR 10-Years
-43%
Otsuka Holdings Co Ltd
TSE:4578
Current Portion of Long-Term Debt
ÂĄ191.2B
CAGR 3-Years
57%
CAGR 5-Years
20%
CAGR 10-Years
9%
Chugai Pharmaceutical Co Ltd
TSE:4519
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Current Portion of Long-Term Debt
ÂĄ307.3B
CAGR 3-Years
43%
CAGR 5-Years
47%
CAGR 10-Years
45%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
38.7B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
1 987.31 JPY
Undervaluation 20%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
7.7B JPY

Based on the financial report for Sep 30, 2024, Fuji Pharma Co Ltd's Current Portion of Long-Term Debt amounts to 7.7B JPY.

What is Fuji Pharma Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
24%

Over the last year, the Current Portion of Long-Term Debt growth was 34%. The average annual Current Portion of Long-Term Debt growth rates for Fuji Pharma Co Ltd have been 45% over the past three years , 18% over the past five years , and 24% over the past ten years .

Back to Top